Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Monte Rosa Therapeutics Inc (NASDAQ: GLUE) closed at $5.58 in the last session, up 6.08% from day before closing price of $5.26. In other words, the price has increased by $6.08 from its previous closing price. On the day, 0.63 million shares were traded. GLUE stock price reached its highest trading level at $5.605 during the session, while it also had its lowest trading level at $5.305.
Ratios:
We take a closer look at GLUE’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.26. For the most recent quarter (mrq), Quick Ratio is recorded 5.61 and its Current Ratio is at 5.61. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $11 from $14 previously.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $11.
Wells Fargo Upgraded its Equal Weight to Overweight on January 03, 2023, while the target price for the stock was maintained at $18.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when Dunn Edmund sold 2,062 shares for $4.45 per share. The transaction valued at 9,174 led to the insider holds 23,732 shares of the business.
Leo Chandra P. bought 10,000 shares of GLUE for $58,383 on Mar 24 ’25. The Director now owns 10,000 shares after completing the transaction at $5.84 per share. On Oct 28 ’24, another insider, Versant Venture Capital VI, L., who serves as the 10% Owner of the company, sold 89,990 shares for $9.66 each. As a result, the insider received 869,240 and left with 2,007,948 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLUE now has a Market Capitalization of 343224672 and an Enterprise Value of 59014800. As of this moment, Monte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 83.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.37 whereas that against EBITDA is 9.607.
Stock Price History:
The Beta on a monthly basis for GLUE is 1.44, which has changed by 0.2768879 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, GLUE has reached a high of $12.40, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is 14.08%, while the 200-Day Moving Average is calculated to be -7.16%.
Shares Statistics:
According to the various share statistics, GLUE traded on average about 435.80K shares per day over the past 3-months and 446860 shares per day over the past 10 days. A total of 61.51M shares are outstanding, with a floating share count of 45.99M. Insiders hold about 25.23% of the company’s shares, while institutions hold 79.30% stake in the company. Shares short for GLUE as of 1752537600 were 8919776 with a Short Ratio of 20.47, compared to 1749772800 on 8872105. Therefore, it implies a Short% of Shares Outstanding of 8919776 and a Short% of Float of 19.229999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 8.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.19 and low estimates of -$0.57.
Analysts are recommending an EPS of between $0.45 and -$0.91 for the fiscal current year, implying an average EPS of -$0.39. EPS for the following year is -$1.38, with 8.0 analysts recommending between -$0.16 and -$2.14.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for GLUE’s current fiscal year. The highest revenue estimate was $175.82M, while the lowest revenue estimate was $85M, resulting in an average revenue estimate of $118.59M. In the same quarter a year ago, actual revenue was $75.62M
